The new joint offering allows hospitals, pharmaceutical companies, and contract research organizations to access de-identified & enriched longitudinal patient data
We are thrilled to announce that Healcloud has signed a strategic partnership with John Snow Labs, joining forces to better support the needs of hospitals, pharmaceutical companies and contract research organizations.
Healcloud, a leading European technology enabler for life sciences research, provides enterprise software to hospitals, clinical research organizations, and pharmaceutical companies, who would like to build virtual data networks that aggregate health Big Data with one tool to support clinical trials, observational studies, population health analytics, and pandemic monitoring.
John Snow Labs Inc. is an award-winning AI and NLP for healthcare company, that provides state-of-the-art software, models, and data to help healthcare and life science organizations build, deploy, and operate AI projects. The company is the developer of Spark NLP, the world’s most widely used NLP library in the enterprise, and its award-winning medical NLP software powers some of the world’s leading healthcare and pharmaceutical companies.
Healcloud and John Snow Labs are setting up a joint offering that allows access to de-identified, enriched, longitudinal data points derived from complex medical data sets, as well as managing data, models, and platforms through AI and NLP to improve medical research and accelerate clinical trials. This collaboration expands both companies’ networks of hospitals, brings value to European and American hospitals and strengthens their research ecosystem. It also answers pharmaceutical companies’ needs in clinical trials units for better data management using state-of-the-art tools.
David Talby, CTO of John Snow Labs, says: “This joint solution enables pharma, CRO, and medical device companies to accelerate clinical trials and real-world evidence projects today, by combining structured and unstructured data sources in a scalable & compliant platform. We’re excited to partner with Healcloud to enable our joint customers to succeed faster.”
Chris Farkas, CEO of Healcloud, says: “By forging this strategic partnership with John Snow Labs, we empower both of our organizations to better fulfill the needs of our clients in pharmaceutical and life sciences research by offering a more comprehensive portfolio of services, a broader mix of GDPR-compliant data and state-of-the AI and NLP tools to be use in data management and curation, as well as additional clinical site coverage across Europe and United States. We look forward to collaborating with our colleagues at John Snow Labs, adding significant value to our clients and clinical research partners.”